274 related articles for article (PubMed ID: 30401319)
1. Severe atopic dermatitis: Therapeutic update.
Kwon CW; Beck LA
Allergy Asthma Proc; 2018 Nov; 39(6):411-419. PubMed ID: 30401319
[No Abstract] [Full Text] [Related]
2. Dupilumab: A review of its use in the treatment of atopic dermatitis.
Gooderham MJ; Hong HC; Eshtiaghi P; Papp KA
J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919
[TBL] [Abstract][Full Text] [Related]
3. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
[TBL] [Abstract][Full Text] [Related]
4. New treatments in atopic dermatitis.
Puar N; Chovatiya R; Paller AS
Ann Allergy Asthma Immunol; 2021 Jan; 126(1):21-31. PubMed ID: 32818591
[TBL] [Abstract][Full Text] [Related]
5. Atopic dermatitis: the updated practice parameter and beyond.
Boguniewicz M
Allergy Asthma Proc; 2014; 35(6):429-34. PubMed ID: 25584909
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].
Gliński W; Kruszewski J; Silny W; Kurzawa R; Czarnecka-Operacz M; Baran E; Szepietowski J;
Pol Merkur Lekarski; 2004; 17 Suppl 3():3-15. PubMed ID: 15688665
[TBL] [Abstract][Full Text] [Related]
7. New and emerging targeted systemic therapies: a new era for atopic dermatitis.
Lee DE; Clark AK; Tran KA; Shi VY
J Dermatolog Treat; 2018 Jun; 29(4):364-374. PubMed ID: 28853956
[TBL] [Abstract][Full Text] [Related]
8. Systemic therapy for atopic dermatitis.
Simon D; Bieber T
Allergy; 2014 Jan; 69(1):46-55. PubMed ID: 24354911
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies for the treatment of atopic dermatitis.
Renert-Yuval Y; Guttman-Yassky E
Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):356-364. PubMed ID: 29870461
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase 4 inhibitors.
Zebda R; Paller AS
J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S43-S52. PubMed ID: 29248522
[TBL] [Abstract][Full Text] [Related]
11. Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases.
Kaufman BP; Alexis AF
Curr Allergy Asthma Rep; 2018 Aug; 18(10):55. PubMed ID: 30171358
[TBL] [Abstract][Full Text] [Related]
12. Dupilumab for the treatment of atopic dermatitis: A clinical trial review.
McGregor S; Farhangian ME; Feldman SR
Expert Opin Biol Ther; 2015; 15(11):1657-60. PubMed ID: 26428945
[TBL] [Abstract][Full Text] [Related]
13. Investigational drugs for atopic dermatitis.
Hon KL; Leung AKC; Leung TNH; Lee VWY
Expert Opin Investig Drugs; 2018 Aug; 27(8):637-647. PubMed ID: 30058384
[TBL] [Abstract][Full Text] [Related]
14. Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD).
Simpson EL; Gadkari A; Worm M; Soong W; Blauvelt A; Eckert L; Wu R; Ardeleanu M; Graham NMH; Pirozzi G; Sutherland ER; Mastey V
J Am Acad Dermatol; 2016 Sep; 75(3):506-515. PubMed ID: 27268421
[TBL] [Abstract][Full Text] [Related]
15. Atopic dermatitis treatment: Current state of the art and emerging therapies.
Silverberg JI
Allergy Asthma Proc; 2017 Jul; 38(4):243-249. PubMed ID: 28668106
[TBL] [Abstract][Full Text] [Related]
16. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis.
Hamilton JD; Suárez-Fariñas M; Dhingra N; Cardinale I; Li X; Kostic A; Ming JE; Radin AR; Krueger JG; Graham N; Yancopoulos GD; Pirozzi G; Guttman-Yassky E
J Allergy Clin Immunol; 2014 Dec; 134(6):1293-1300. PubMed ID: 25482871
[TBL] [Abstract][Full Text] [Related]
17. Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies.
Boguniewicz M; Alexis AF; Beck LA; Block J; Eichenfield LF; Fonacier L; Guttman-Yassky E; Paller AS; Pariser D; Silverberg JI; Lebwohl M
J Allergy Clin Immunol Pract; 2017; 5(6):1519-1531. PubMed ID: 28970084
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
[TBL] [Abstract][Full Text] [Related]
19. Adverse events of Dupilumab in adults with moderate-to-severe atopic dermatitis: A meta-analysis.
Ou Z; Chen C; Chen A; Yang Y; Zhou W
Int Immunopharmacol; 2018 Jan; 54():303-310. PubMed ID: 29182975
[TBL] [Abstract][Full Text] [Related]
20. Biologic Therapy for Atopic Dermatitis: Moving Beyond the Practice Parameter and Guidelines.
Boguniewicz M
J Allergy Clin Immunol Pract; 2017; 5(6):1477-1487. PubMed ID: 29122151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
